Dedicated solution for the preclinical evaluation of gene therapies

2 septembre 2021

Dedicated solution for the preclinical evaluation of gene therapies

 

Cynbiose offers a range of preclinical services related to pharmacology and safety studies for gene therapy medicinal products in a relevant translational in vivo model.

More information on our dedicated offer is available on our web site , please contact us to discuss your projects and needs.

Share this!